Clearing Up What the Sunshine Act Means to Healthcare
Starting Sept. 30 as part of the Sunshine Act, patients will be able to search a government database for any payment or items of value given to any individual U.S. physician by a pharmaceutical company. The anticipated implementation of the Sunshine Act through the Centers of Medicare & Medicaid Services’ Open Payments Program is expected to garner a mix of opinions – and raise questions about the financial relationships between the pharmaceutical industry and physicians. In the webinar “The Sunshine Act: Anticipated Outcomes and Impact on Healthcare,” FleishmanHillard’s Mark Senak, author of the blog Eye on FDA, examines the potentially profound communications ramifications for the healthcare industry, physicians and patients. In addition, the session questions what can be done – and what should be done – to prepare for the launch.